LUREX BIO, INC
through Aug 31, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Feb 5, 2026 · D | Aug 31, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | — | — | — |
| Reported amount sold | $50,000 | $150,000 | $100,000 |
| Reported investor count | — | 3 | — |
| Reported minimum investment | $50,000 | $50,000 | $0 |
Earlier SEC source: 0002108090-26-000002 · Later SEC source: 0002108090-26-000004
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- —
- Reported amount sold
- $150,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0002108090-26-000004D/A · Aug 31, 2026 · BiotechnologySold: $150,000
-
0002108090-26-000002D · Feb 5, 2026 · Other TechnologySold: $50,000